Patients with hereditary spherocytosis, especially parents of younger children will benefit from comprehensive educational supplementation. These patients will require periodical follow up, and monitoring. Ideally, they should be able to identify early signs and symptoms of disease complications such as aplastic crises or cholelithiasis.

Affected patients who undergo splenectomy will require additional prophylactic vaccination against encapsulated organisms and follow-up to monitor for complications.

For patients who have moderate disease, the decision to perform splenectomy is controversial and extensive counseling, and educational plan are warranted before drawing a conclusion, there should be a consensus should between the patient, family, and physicians.